NORVASC Safety Information
Important Safety Information
NORVASC is indicated for the treatment of hypertension and angina.
In clinical trials, the most common side effects versus placebo were edema (8.3%
vs 2.4%), headache (7.3% vs 7.8%), fatigue (4.5% vs 2.8%), and dizziness (3.2% vs
3.4%).
Generally CCBs should be used with caution in patients with heart failure. In studies
with NORVASC, there has been no evidence of worsened heart failure.